跳到正文
原文
NEJM· @NEJM · X·· 2 天前AI 评分22
AI 导读

疟疾防控面临抗性威胁:非洲2000-2015年病例下降68%主要归功于驱虫蚊帐,但杀虫剂抗性媒介扩散及恶性疟原虫对磺胺多辛-乙胺嘧啶和阿莫地喹的高水平耐药正在削弱进展。2023年起两类新型驱虫蚊帐上市,2024年季节性疟疾化学预防在撒哈拉以南非洲19国保护了5400万儿童,两种WHO预认证疟疾疫苗正在非洲推广。生物与遗传学方法亦显现前景。

正文

Resistance threatens existing preventive tools for malaria. Next-generation bed nets are now available, and biologic and genetic approaches show promise. New vaccines offer protection for young children. 🔗 https://nej.md/4sQ0qLg

The fight against malaria is inherently dynamic. The evolutionary imperative warrants the rapid development and implementation of new approaches to keep ahead of the parasite. Sustaining progress — even maintaining current gains — demands relentless effort. Malaria control and prevention is often most needed in remote and economically limited areas and is fragile to disruptions caused by natural disasters, shifts in climate, environmental degradation, human conflict, and economic contraction. Sri Lanka is the salient example of curtailing malaria control, where six indigenous cases in 1963 surged to over half a million within 6 years.

Extensive deployment of insecticide-treated nets accounted for 68% of malaria case reduction in Africa between 2000 and 2015. Hence, the increased prevalence of insecticide-resistant vectors has substantially contributed to declining momentum against malaria over the past decade. Likewise, chemoprevention is threatened by the emergence and spread of high-level Plasmodium falciparum resistance to sulfadoxine–pyrimethamine and amodiaquine.

On a more positive note, two new classes of insecticide-treated net became available as of 2023, transforming the vector-control space. Seasonal malaria chemoprevention protected 54 million children across 19 countries in sub-Saharan Africa in 2024 (seen in Panel A). In addition, two World Health Organization (WHO)–prequalified malaria vaccines are being deployed across Africa.

Learn more in a new review: https://nej.md/4sQ0qLg

来源:NEJM · x.com